Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism in Individuals With Type 2 Diabetes in Wakiso District, Uganda
1 other identifier
interventional
8
0 countries
N/A
Brief Summary
The goal of this clinical trial is to evaluate changes in glucose and lipid levels after consuming challenge meals enriched with selected indigenous fruits and vegetables in people living with type 2 diabetes in Wakiso district. The main question to answer is: Does the consumption of challenge meals enriched with indigenous fruits and vegetables improve glucose and lipid levels among people living with type 2 diabetes? Researchers will compare the effects of different challenge meals on glucose and lipid levels to identify the indigenous fruit and vegetable with the strongest glucose- and lipid-lowering effects. Participants will: Consume five challenge meals over 5 weeks. Visit the study site after a 5-7 day rest period to consume the challenge meal and complete the tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started May 2026
Shorter than P25 for not_applicable type-2-diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedStudy Start
First participant enrolled
May 13, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
Study Completion
Last participant's last visit for all outcomes
July 30, 2026
May 6, 2026
April 1, 2026
3 months
December 3, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incremental area under the curve blood glucose
Blood glucose analysis for blood samples collected at 8 different time points:0, 15, 30, 60, 90, 120, 150 and 180 minutes
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
Secondary Outcomes (6)
Incremental area under the curve blood triglyceride
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
Incremental area under the curve high density lipoprotein cholestrol (HDL)
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
Incremental area under the curve low density lipoprotein cholestrol (LDL)
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
Incremental area under the curve total cholestrol
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
Incremental area under the curve plasma polyphenol metabolites
From enrollment at each of the five postprandial visits, until the end of the postprandial study which will last five weeks
- +1 more secondary outcomes
Other Outcomes (3)
Body mass Index (BMI)
BMI will be calculated only on day one of the study that lasts five weeks
Fat mass
Fat mass will be calculated only on day one of the study that lasts five weeks
Waist circumference
Waist circumference will be calculated only on day one of the study that lasts five weeks
Study Arms (5)
Challenge meal enriched with Hibiscus sabdariffa (Hibiscus)
EXPERIMENTALChallenge meal enriched with Solunum anguivi (Forest bitter berries)
EXPERIMENTALChallenge meal enriched withTamarindus indica (Tamarind)
EXPERIMENTALReference meal one
ACTIVE COMPARATORReference meal two
ACTIVE COMPARATORInterventions
Indigenous fruit and vegetable freeze dried powder.
Isocaloric challenge meal
Eligibility Criteria
You may qualify if:
- Fasting blood sugar \>= \[7 mmol/L\](based on medical records)
- Diabetic regimen for at least 6 months
- Type 2 diabetes
- Plans to continue staying in the same location for the next 6 months
You may not qualify if:
- Taking dietary supplements
- Type 1 diabetes
- Tuberculosis co-infection
- Renal failure
- Liver cirrhosis
- Chronic pancreatitis
- Pregnancy and Lactation
- Regular sports activity
- Parallel participation in another clinical trial
- On treatment for dyslipidaemia,
- On treatment for hypertension
- Very low blood pressure (\< 90/50 mmHg)
- Allergic reactions to test products
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Matthys, Phd
KU Leuven University, Belgium
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Proffessor
Study Record Dates
First Submitted
December 3, 2025
First Posted
December 19, 2025
Study Start (Estimated)
May 13, 2026
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 9 to 18 months after article publication.
Individual Participant Data (IPD) Sharing Statement Plan to Share IPD: Plan Description: All the data generated during this study will comply with the prevailing standards and guidelines in documenting and depositing data sets. The results from this research will be disseminated in presentations at public lectures, scientific institutions and meetings, and/or publication in reputable journals. Data sharing will be performed in compliance with the International Committee of Medical Journal Editors. Individual de-identified participant data will be shared. In particular, individual participant data that underlie the results reported in our articles, after de-identification (text, tables, figures and appendices). Supporting Materials: Study Protocol Informed Consent Form (ICF) Analytic Code Time Frame: Data will become available from 9-36 months after the publication of the study results by the research team. Access Criteria: Data will only be shared with investigators